Evidence map›Paper›PMID 39418301›Full record

ArticlePLoS computational biology2024

Partial correlation network analysis identifies coordinated gene expression within a regional cluster of COPD genome-wide association signals.

Michele Gentili, Kimberly Glass, Enrico Maiorino, Brian D Hobbs, Zhonghui Xu, Peter J Castaldi, Michael H Cho, Craig P Hersh, Dandi Qiao, Jarrett D Morrow and 3 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Identification ofFrontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michele GentiliChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0003-2282-2227
Kimberly GlassChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Enrico MaiorinoChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Brian D HobbsChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Zhonghui XuChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Peter J CastaldiChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Michael H ChoChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-4907-1657
Craig P HershChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Dandi QiaoChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Jarrett D MorrowChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Vincent J CareyChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
John PlatigDepartment of Genome Sciences, University of Virginia, Charlottesville, Virginia, United States of America.
Edwin K SilvermanChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-3641-3822

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SILVERMAN, EDWIN K · 2013 to 2025
$24.9M
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and GeneticsR01HL133135 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORITZ, ROBERT L, SILVERMAN, EDWIN K · 2017 to 2025
$7.2M
Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTLR01HL124233 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CASTALDI, PETER · 2014 to 2024
$7.1M
Leveraging Variant-perturbed Gene Regulation to Support Precision Medicine in COPDR01HL155749 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Kimberly Renee Glass · 2022 to 2026
$4.2M
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4qR01HL147148 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHO, MICHAEL H., SILVERMAN, EDWIN K · 2019 to 2022
$3.5M
Identifying Protein-Protein Network Interactions between COPD Susceptibility GenesR01HL152728 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K, WEI, WENYI · 2021 to 2024
$3.2M
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPDR01HL153248 · NHLBI · UNIVERSITY OF VIRGINIA · PI CHO, MICHAEL H., MANICHAIKUL, ANI WANG · 2021 to 2024
$2.8M
Prospective Health Outcomes and Inflammatory Biomarkers Associated with e-Cigarette UseR01HL147326 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CASTALDI, PETER · 2019 to 2021
$1.5M
Integrative omics pipeline to identify novel COPD genes and pathwaysK25HL136846 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORROW, JARRETT · 2017 to 2021
$945k
Context matters: Network modeling of COPD regulatory variants across tissues and exposuresK25HL140186 · NHLBI · UNIVERSITY OF VIRGINIA · PI PLATIG, JOHN · 2018 to 2022
$926k
Linking endotype and phenotype to understand COPD heterogeneity via deep learning and network scienceK01HL166705 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Enrico Maiorino · 2023 to 2026
$713k
NHLBI NIH HHS K01 HL166705NHLBI NIH HHS K25 HL136846NHLBI NIH HHS K25 HL140186NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL124233NHLBI NIH HHS R01 HL133135NHLBI NIH HHS R01 HL147148NHLBI NIH HHS R01 HL147326NHLBI NIH HHS R01 HL152728NHLBI NIH HHS R01 HL153248NHLBI NIH HHS R01 HL155749
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex disease influenced by well-established environmental exposures (most notably, cigarette smoking) and incompletely defined genetic factors. The chromosome 4q region harbors multiple genetic risk loci for COPD, including signals near HHIP, FAM13A, GSTCD, TET2, and BTC. Leveraging RNA-Seq data from lung tissue in COPD cases and controls, we estimated the co-expression network for genes in the 4q region bounded by HHIP and BTC (~70MB), through partial correlations informed by protein-protein interactions. We identified several co-expressed gene pairs based on partial correlations, including NPNT-HHIP, BTC-NPNT and FAM13A-TET2, which were replicated in independent lung tissue cohorts. Upon clustering the co-expression network, we observed that four genes previously associated to COPD: BTC, HHIP, NPNT and PPM1K appeared in the same network community. Finally, we discovered a sub-network of genes differentially co-expressed between COPD vs controls (including FAM13A, PPA2, PPM1K and TET2). Many of these genes were previously implicated in cell-based knock-out experiments, including the knocking out of SPP1 which belongs to the same genomic region and could be a potential local key regulatory gene. These analyses identify chromosome 4q as a region enriched for COPD genetic susceptibility and differential co-expression.

Indexed as

Gene Regulatory NetworksGenetic Predisposition to DiseaseGenome-Wide Association StudyPulmonary Disease, Chronic ObstructiveCase-Control StudiesChromosomes, Human, Pair 4Computational BiologyHumans

Identifiers

PMID39418301
PMCPMC11521246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.